INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 46 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $9,600,523 | -32.6% | 9,506,000 | -33.2% | 0.13% | -19.7% |
Q1 2023 | $14,236,510 | +34.7% | 14,234,000 | +33.3% | 0.16% | +41.4% |
Q4 2022 | $10,570,516 | +9.1% | 10,677,000 | +7.2% | 0.11% | +4.7% |
Q3 2022 | $9,690,000 | +43.3% | 9,964,000 | +43.0% | 0.11% | +34.2% |
Q2 2022 | $6,760,000 | +6.7% | 6,970,000 | +4.7% | 0.08% | +19.7% |
Q1 2022 | $6,338,000 | +3.1% | 6,655,000 | +2.5% | 0.07% | -1.5% |
Q4 2021 | $6,149,000 | -58.5% | 6,494,000 | -60.5% | 0.07% | -66.3% |
Q2 2021 | $14,816,000 | -15.6% | 16,435,000 | -23.3% | 0.20% | -18.4% |
Q1 2021 | $17,550,000 | +16.4% | 21,435,000 | +10.3% | 0.24% | -6.2% |
Q4 2020 | $15,079,000 | -31.2% | 19,435,000 | -28.3% | 0.26% | -45.5% |
Q3 2020 | $21,933,000 | +8.7% | 27,113,000 | +1.8% | 0.48% | +6.5% |
Q2 2020 | $20,172,000 | +282.9% | 26,629,000 | +317.0% | 0.45% | +202.7% |
Q1 2020 | $5,268,000 | +35.0% | 6,386,000 | +65.4% | 0.15% | +100.0% |
Q4 2019 | $3,902,000 | -22.6% | 3,861,000 | -33.8% | 0.07% | -25.3% |
Q3 2019 | $5,041,000 | -5.6% | 5,828,000 | -2.2% | 0.10% | -1.0% |
Q2 2019 | $5,342,000 | -57.7% | 5,959,000 | -53.0% | 0.10% | -58.3% |
Q1 2019 | $12,621,000 | -78.9% | 12,689,000 | -80.3% | 0.24% | -55.9% |
Q4 2018 | $59,704,000 | +35.7% | 64,452,000 | +48.8% | 0.54% | -8.1% |
Q3 2018 | $43,995,000 | +44.9% | 43,316,000 | +25.7% | 0.59% | +39.6% |
Q2 2018 | $30,352,000 | +3.0% | 34,470,000 | -5.7% | 0.42% | -9.4% |
Q1 2018 | $29,477,000 | +29.7% | 36,560,000 | +28.7% | 0.47% | +31.5% |
Q4 2017 | $22,732,000 | +131.8% | 28,415,000 | +184.2% | 0.36% | +122.5% |
Q2 2017 | $9,807,000 | -53.8% | 10,000,000 | -47.1% | 0.16% | -42.0% |
Q3 2016 | $21,245,000 | – | 18,900,000 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Worth Venture Partners, LLC | 5,324,000 | $4,995,000 | 3.78% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 57,791,000 | $53,020,000 | 2.12% |
DLD Asset Management, LP | 32,500,000 | $30,048,000 | 2.06% |
Castle Creek Arbitrage, LLC | 4,504,000 | $4,161,000 | 1.43% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 10,000,000 | $9,372,000 | 0.62% |
Graham Capital Management, L.P. | 14,636,000 | $13,509,000 | 0.60% |
OAKTREE CAPITAL MANAGEMENT LP | 64,452,000 | $59,704,000 | 0.54% |
Context Capital Management, LLC | 1,000,000 | $926,000 | 0.52% |
ADVENT CAPITAL MANAGEMENT /DE/ | 23,118,000 | $21,341,000 | 0.52% |
WOLVERINE ASSET MANAGEMENT LLC | 18,583,000 | $17,322,000 | 0.21% |